Welcome to the psychedelic renaissance.
Reid Robison, MD, MBA
Advertisement
Dr Robison is chief medical officer of Novamind; medical director for the Center for Change; and coordinating investigator for the Multidisciplinary Association for Psychedelic Studies’ phase 2 clinical trial examining MDMA-assisted psychotherapy for the treatment of eating disorders.
Articles by Reid Robison, MD, MBA
Advertisement
Latest Updated Articles
Psychedelics and the Future of PsychiatryPublished: February 8th 2022 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Social Challenge of the Powerful Taking Care of the Poor: Columbus Day, Indigenous People’s Day, and More
2
Asynchronous ADHD Assessment: New Tools for Better Evaluation
3
Women Are Diagnosed With ADHD 5 Years Later Than Men
4
Early Dose Management and Up-Titration of Esketamine: ECNP Poster Data
5
